기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
XBiotech Inc | XBIT | 나스닥 | 보통주 |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
8.26 | 8.02 | 8.69 | 8.02 | 8.16 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
08/02/2024 | 02:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
08/02/2024 | 02:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
06/01/2024 | 00:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
04/01/2024 | 23:00 | EDGAR2 | Form 8-K - Current report |
04/01/2024 | 23:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
14/11/2023 | 23:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
10/11/2023 | 04:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
26/09/2023 | 22:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
30/08/2023 | 22:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
12/08/2023 | 00:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/08/2023 | 00:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
22/05/2023 | 22:00 | GLOBE | FDA Authorizes Phase II Study for Natrunix in Rheumatoid.. |
17/05/2023 | 22:00 | GLOBE | XBiotech Commences Tender Offer to Purchase up to.. |